Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

BIOCEPT RG (NQ: )

N/A USD UNCHANGED
Last Price Updated: 8:00 PM EDT, Jul 27, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about BIOCEPT RG

Biocept and UC San Diego Moores Cancer Center Announce Collaboration to Study Feasibility of Liquid Biopsy to Predict Disease Recurrence in Solid Tumors and Response to Therapy
Clinical studies with Biocept's Target Selector™ to evaluate the use of circulating tumor cells in disease assessment, surveillance and monitoring 
From PR Newswire
Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record
To be a shareholder of record, investors are advised to own Biocept stock by 4:00 PM ET, Thursday, July 19, 2018 to account for T+2 settlement timing 
From PR Newswire
Biocept Enters into Agreement with Alliance Global FZ to Market and Distribute Liquid Biopsy Testing in the Middle East, Southeast Asia, and Africa Region
Expands international distribution of Target Selector™ platform to 17 countries 
From PR Newswire
Thinking about buying stock in Advanced Micro Devices, Biocept, Chesapeake Energy, Papa John's Int'l, Inc. or Twitter?
InvestorsObserver issues critical PriceWatch Alerts for AMD, BIOC, CHK, PZZA, and TWTR. 
From PR Newswire
Biocept Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Biocept, Inc. (NASDAQ: BIOC) ("Biocept"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients... 
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.